AUPH R&D Expenses
Aurinia Pharmaceuticals Inc · R&D Expenses
AUPH R&D Expenses
Latest reported$39.85Mperiod ending
AUPH TTM R&D Expenses ($1.43M → $39.85M)
TTM R&D Expenses
High-resolution chart · PNG
AUPH r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 39,850,000 | |
| 34,232,000 | |
| 32,505,000 | |
| 29,717,000 | |
| 24,329,000 | |
| 20,977,000 | |
| 20,785,000 | |
| 22,906,000 | |
| 33,464,000 | |
| 42,034,000 | |
| 49,641,000 | |
| 49,283,000 | |
| 46,651,000 | |
| 45,526,000 | |
| 44,988,000 | |
| 46,267,000 | |
| 55,360,000 | |
| 53,926,000 | |
| 51,139,000 | |
| 53,163,000 | |
| 45,340,000 | |
| 46,325,000 | |
| 50,327,000 | |
| 50,446,000 | |
| 55,994,000 | |
| 56,070,000 | |
| 52,866,000 | |
| 50,413,000 | |
| 43,774,000 | |
| 43,126,000 | |
| 41,382,000 | |
| 39,234,000 | |
| 38,889,000 | |
| 35,492,000 | |
| 33,930,000 | |
| 30,701,000 | |
| 23,236,000 | |
| 18,535,000 | |
| 14,534,000 | |
| 12,724,000 | |
| 14,052,000 | |
| 15,976,000 | |
| 15,982,000 | |
| 15,422,000 | |
| 13,185,000 | |
| 11,402,000 | |
| 9,112,000 | |
| 6,660,589 | |
| 4,754,935 | |
| 2,637,527 | |
| 1,929,730 | |
| 4,590,852 | |
| 4,626,371 | |
| 5,000,043 | |
| 5,471,680 | |
| 3,109,594 | |
| 3,289,718 | |
| 3,601,557 | |
| 3,601,289 | |
| 3,630,091 | |
| 3,558,743 | |
| 3,414,136 | |
| 4,001,578 | |
| 5,193,133 | |
| 6,241,952 | |
| 6,659,112 | |
| 7,184,626 | |
| 6,118,018 | |
| 7,342,012 | |
| 9,905,033 | |
| 11,697,822 | |
| 18,226,569 | |
| 21,944,081 | |
| 26,252,680 | |
| 28,187,433 | |
| 25,279,450 | |
| 23,631,813 | |
| 20,191,241 | |
| 18,825,777 | |
| 18,634,330 | |
| 18,699,775 | |
| 18,874,377 | |
| 18,999,342 | |
| 19,966,988 | |
| 19,811,135 | |
| 15,995,482 | |
| 13,381,847 | |
| 11,041,586 | |
| 8,085,612 | |
| 8,860,474 | |
| 8,968,642 | |
| 2,209,058 | |
| 2,913,364 | |
| 5,867,542 | |
| 7,307,578 | |
| 12,650,358 | |
| 12,670,102 | |
| 9,456,791 | |
| 8,073,205 | |
| 7,479,891 |